WNT signals in hip cartilage and osteoarthritis
Official title: WNT signaling in chondrocyte biology and osteoarthritis
Funded at University of Rochester · NIH-11382101 · Data updated 2026-11-12
A study from the University of Rochester is examining how a cellular signaling pathway called WNT, and a mechanosensor in cartilage cells, influence Hip OA progression and how this could lead to new therapies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $572,611 |
| NIH project number | 5R01AR082403-03 |
| Project ID | NIH-11382101 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with hip osteoarthritis or cam-type FAI who provide cartilage tissue or participate in related cell studies may contribute.
✕Less likely to help
People without OA or hip cartilage samples are unlikely to benefit directly.
What this research studies
This project looks at knee? actually hip osteoarthritis and Cam-type impingement, using cartilage samples and stem-cell–derived chondrocytes to study how mechanical loading and TRPV4 signaling affect WNT16, a gene linked to OA. Researchers will apply loading to cell constructs with TRPV4 activators or inhibitors and measure how WNT16 changes, aiming to uncover how mechanoinduction drives disease. The work could reveal targets to prevent chondrocyte hypertrophy and slow OA progression. It spans genetic and epigenetic mechanisms, cell culture models, and potential pathways for therapy development.
Why it matters
Potential benefit: If successful, findings could identify new targets to slow or halt hip OA by modulating WNT16 and mechanosignaling in cartilage.
How similar studies have gone: Prior work shows WNT signaling influences cartilage biology, but this project explores a novel link with mechanosensing and WNT16 in human chondrocytes, which is still exploratory.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Wu, Chia-Lung — University of Rochester
- Study coordinator: Wu, Chia-Lung
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.